Raydiant Oximetry: Funding, Investors & Team (Sep 2026)
Raydiant Oximetry is a medical device company that aims to enhance the health outcomes for expecting mothers and babies through the creation of affordable and non-invasive technology to monitor fetal oxygen levels. This innovative technology, developed by founder Neil Ray in 2015 and based in Mountain View, California, will improve patient care and decrease the need for unnecessary cesarean sections.
Raydiant Oximetry has raised $12.5M across 2 funding rounds on record, the most recent a Series A of $7.5M announced in Jun 2024.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Raydiant Oximetry Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Raydiant Oximetry Funding Rounds
Raydiant Oximetry raised $5.0M in a Series A announced in Nov 2021.
2.6 years later, a Series A of $7.5M was announced in Jun 2024.
Raydiant Oximetry Founders and Leadership Team
Contact details for the Raydiant Oximetry team: 1 of 1 has an email address on file.
Start 14-day free trial →Raydiant Oximetry Funding Compared to Other Biotechnology Startups
Raydiant Oximetry's latest round of $7.5M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Raydiant Oximetry in Biotechnology and San Ramon
Companies Similar to Raydiant Oximetry
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Raydiant Oximetry Funding FAQs
What does Raydiant Oximetry do?
Raydiant Oximetry is a medical device company that aims to enhance the health outcomes for expecting mothers and babies through the creation of affordable and non-invasive technology to monitor fetal oxygen levels. This innovative technology, developed by founder Neil Ray in 2015 and based in Mountain View, California, will improve patient care and decrease the need for unnecessary cesarean sections.
How much funding has Raydiant Oximetry raised?
Raydiant Oximetry has raised $12.5M across 2 rounds on record. The most recent is a Series A of $7.5M announced in Jun 2024.
When did Raydiant Oximetry last raise funding?
Raydiant Oximetry's most recent funding round on record is a Series A of $7.5M, announced in Jun 2024.
Who founded Raydiant Oximetry?
FundedIQ lists Neil Ray (Founder) at Raydiant Oximetry.
Where is Raydiant Oximetry headquartered?
Raydiant Oximetry is based in San Ramon, California, United States.
How many employees does Raydiant Oximetry have?
Raydiant Oximetry is in the 11-50 employee band.
How does Raydiant Oximetry's funding compare to other Biotechnology startups?
Raydiant Oximetry's latest round of $7.5M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Raydiant Oximetry Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Raydiant Oximetry is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.